文献速递创面修复烧伤瘢痕与激光

表皮移植与刃厚皮移植随机对照试验:供区并发症更低且患者满意度更高

Lower donor site morbidity and higher patient satisfaction with epidermal grafting in comparison to split thickness skin grafting: A randomized controlled trial (EPIGRAAFT Trial).
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2020-03-16

EPIGRAAFT 为一项 2 期随机开放标签平行对照试验,纳入 44 例健康肉芽创面患者,比较表皮移植(EG)与刃厚皮移植(SSG)。两组 6 周和 3 个月创面愈合比例及平均愈合时间均无差异;EG 供区并发症更低、供区愈合更快(4.86 天 vs. 21.32 天)、总体满意度更高,均未报告不良事件。

要点

  • EG 与 SSG 的创面愈合比例及平均愈合时间无显著差异。
  • EG 供区愈合时间 4.86 天,显著短于 SSG 的 21.32 天。
  • EG 供区并发症更低且患者总体满意度更高,未见不良事件。

核心结论

  • EG 供区结局优于 SSG,供区愈合更快且并发症更低。
  • EG 与 SSG 的创面愈合结局相当。
  • 接受 EG 的患者供区满意度高于 SSG。

研究设计与样本

  • EPIGRAAFT 为 2 期随机开放标签平行对照试验,设 EG 与 SSG 两组。
  • 纳入因健康肉芽创面需植皮的患者,筛查 61 例,随机 44 例。
  • 共同主要终点为创面愈合比例与供区愈合时间。

主要发现

  • 6 周创面愈合比例两组无差异(p=0.366)。
  • 3 个月创面愈合比例两组无差异(p=0.24)。
  • 平均创面愈合时间两组无差异(p=0.12)。
  • EG 供区并发症更低(p=0.001)。
  • 供区愈合时间 EG 4.86 天 vs. SSG 21.32 天(p<0.0001)。

关键数值与推荐

  • 共同主要终点:创面愈合比例、供区愈合时间。
  • 供区并发症采用温哥华瘢痕量表评估。
  • 患者满意度采用经验证的植皮问卷评估。

临床怎么用

  • 对健康肉芽创面需自体植皮者,可考虑 EG 以降低供区并发症并加快供区愈合。
  • EG 可作为 SSG 的临床替代方案,创面愈合结局相当。
  • 选择术式时应结合供区愈合速度与患者满意度进行个体化决策。

局限性

  • 原文摘要未报告盲法实施细节。
  • 原文摘要未报告样本量计算依据。
  • 原文摘要未报告随访时长及长期瘢痕结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Split thickness skin grafting (SSG) is an important modality for wound coverage; however, it leads to donor site morbidity. Epidermal grafting (EG) is a promising option for autologous skin grafting which offers minimal donor site morbidity, though it is not known if EG is an effective clinical alternative for SSG. This study compared the efficacy of EG as an alternative to SSG in terms of wound healing outcomes, donor site morbidity, patient satisfaction and adverse events. METHODS: EPIGRAAFT is a Phase 2, randomized, open-label trial with two parallel groups: EG and SSG. Patients referred for skin grafting with a healthy granulating wound bed were included. The co-primary endpoints were the proportion of wounds healed and donor site healing time. The secondary endpoints include donor site morbidity measured using Vancouver Scar Scale, mean time for complete wound healing, patient satisfaction assessed using a validated skin grafting questionnaire and incidence of adverse events. RESULTS: Of the 61 patients screened, 44 patients were randomized. There was no difference in the proportion of wounds healed at 6 weeks (p=0.366) and 3 months(p=0.24) as well as the mean time for wound healing (p=0.12). EG resulted in lower donor site morbidity (p=0.001), faster donor site healing time (EG: 4.86 days vs. SSG: 21.32 days) (p<0.0001), and higher overall satisfaction (p<0.001). There were no adverse events reported. CONCLUSION: This study demonstrated that EG has superior donor site outcomes with faster donor site healing and lower morbidity compared to SSG, while having comparable wound healing outcomes. Patients receiving EG also experienced higher donor site satisfaction compared to SSG. ClinicalTrials.gov identifier: NCT02535481.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Kanapathy M, Bystrzonowski N, Hachach-Haram N, et al. Lower donor site morbidity and higher patient satisfaction with epidermal grafting in comparison to split thickness skin grafting: A randomized controlled trial (EPIGRAAFT Trial). J Plast Reconstr Aesthet Surg. 2020. PMID: 32532631. doi:10.1016/j.bjps.2020.03.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。